1. Home
  2. CSGS vs SRPT Comparison

CSGS vs SRPT Comparison

Compare CSGS & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSG Systems International Inc.

CSGS

CSG Systems International Inc.

HOLD

Current Price

$80.69

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$18.71

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSGS
SRPT
Founded
1994
1980
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.5B
IPO Year
1996
2000

Fundamental Metrics

Financial Performance
Metric
CSGS
SRPT
Price
$80.69
$18.71
Analyst Decision
Hold
Hold
Analyst Count
5
29
Target Price
$77.23
$25.85
AVG Volume (30 Days)
308.4K
2.6M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
1.69%
N/A
EPS Growth
N/A
N/A
EPS
0.83
2.88
Revenue
$996,810,000.00
$2,198,237,000.00
Revenue This Year
$5.45
N/A
Revenue Next Year
$3.02
N/A
P/E Ratio
$97.23
$6.56
Revenue Growth
13.91
15.58
52 Week Low
$60.54
$10.42
52 Week High
$80.73
$44.14

Technical Indicators

Market Signals
Indicator
CSGS
SRPT
Relative Strength Index (RSI) 70.19 38.51
Support Level $80.13 $18.38
Resistance Level N/A $19.62
Average True Range (ATR) 0.19 1.08
MACD 0.02 -0.37
Stochastic Oscillator 93.62 1.76

Price Performance

Historical Comparison
CSGS
SRPT

About CSGS CSG Systems International Inc.

CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, it generates revenue from the United States.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: